Cephalon Launches Takeover Bid For Australian Biotech Arana
PERTH, Australia - Sydney-based biotech Arana Therapeutics announced Feb. 27 that Cephalon intends to make a cash takeover offer for all of Arana's shares at a price of $1.40 per share
PERTH, Australia - Sydney-based biotech Arana Therapeutics announced Feb. 27 that Cephalon intends to make a cash takeover offer for all of Arana's shares at a price of $1.40 per share